Innovative drugs for cancer patients

Our values, experience and committed employees are the key to developing new drugs for which we ultimately achieve market approval.

Learn more about our clinical trials

Pioneering spirit is our driving force

Seeking answers, making discoveries, finding solutions – our forces to fight cancer.

Learn more about our products

One team – one goal

We are united by shared values, a sense of fairness and our common goals - the success of our compounds.

Learn more about 4SC

Success secures our future

Experience and expertise lead to sound results and recognition – the foundation for our success.

Learn more about our perspectives

Transparency for partners

Continuous exchange and open communication create value and long-standing partnerships.

Learn more about our partners

4SC AG: Developing innovative drugs for cancer patients

Headquartered in Planegg-Martinsried near Munich/Germany, 4SC is an innovative biopharmaceutical company with a strong focus on clinical development.

We develop novel small molecule drugs for the treatment of cancer in indications with a high unmet medical need and major economic potential.

We wish to offer affected patients treatment options that are more effective and better tolerated to provide a better quality of life.

Our product pipeline comprises promising drug programs at various stages of clinical development. We are focusing on fields of research with an especially promising future – such as epigenetics, cancer stem cells, cancer immunotherapy and other, important cell signaling pathways that contribute to the development and persistence of cancer.

Learn more about 4SC

Share this page:

Follow us on: